Express Scripts (ESRX): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Express Scripts ( ESRX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, Express Scripts rose $1.69 (2.8%) to $62.63 on heavy volume. Throughout the day, 10,001,833 shares of Express Scripts exchanged hands as compared to its average daily volume of 4,228,400 shares. The stock ranged in a price between $61.02-$63.47 after having opened the day at $61.17 as compared to the previous trading day's close of $60.94. Other companies within the Health Services industry that increased today were: MAKO Surgical Corporation ( MAKO), up 82.2%, Hansen Medical ( HNSN), up 14.9%, BioScrip ( BIOS), up 8.5% and Stereotaxis ( STXS), up 8.2%.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $50.7 billion and is part of the health care sector. Shares are up 15.3% year to date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the negative front, Abiomed ( ABMD), down 7.4%, Baxter International ( BAX), down 6.4%, Spherix ( SPEX), down 5.7% and Navidea Biopharmaceuticals ( NAVB), down 5.6% , were all laggards within the health services industry with Medtronic ( MDT) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Here's How to Invest Like a Billionaire

The Dow Binges on Earnings

Alphabet Slides After a So-So Quarter - 5 Things You Must Know Before the Market Opens